Join to View Full Profile
2 Tampa General CirUsf Vascular Surgery Ste.300Tampa, FL 33606
Phone+1 813-259-0921
Fax+1 813-259-0606
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Karl Illig, MD is a vascular surgeon in Tampa, Florida. He is currently licensed to practice medicine in Florida, Texas, and South Carolina.
Education & Training
University of Rochester Medical CenterFellowship, Vascular Surgery - Independent, 1995 - 1997- University of Rochester Medical CenterResidency, Surgery, 1988 - 1995
Weill Cornell MedicineClass of 1988
Certifications & Licensure
TX State Medical License 2021 - 2026
SC State Medical License 2018 - 2023
FL State Medical License 2011 - 2022
NY State Medical License 1989 - 2018
American Board of Surgery Vascular Surgery
Publications & Presentations
PubMed
- 2 citationsThe role of surgery for assisted maturation after endovascular and percutaneous arteriovenous fistula creationKarl A. Illig, Charmaine E. Lok, Dheeraj K. Rajan, John Aruny, Eric K. Peden
The Journal of Vascular Access. 2021-09-01 - 6 citationsInvited Review: Optimal Management of Upper Extremity DVT: Is Venous Thoracic Outlet Syndrome Underrecognized?Karl A. Illig, Leah Gober
Journal of Vascular Surgery. Venous and Lymphatic Disorders. 2021-08-02 - Results of first stage brachiobasilic and brachiobrachial fistula creation: Implications for staged versus single procedure decision making.Mary E. Ottinger, Desiree Picone, Katrina Hseih, Mathew Wooster, Mark J London
The Journal of Vascular Access. 2021-05-03
Authored Content
- Arteriovenous Access Superficialization: A New Technique and Review of OptionsSeptember 2018
- IP107. Hemodynamic Events During Carotid Stenting Are Associated with SignificantMay 2018
- IP243. The Picture of a Vascular SurgeonMay 2018
Press Mentions
Xeltis Announces FDA Breakthrough Device Designation for aXessTM and First Patient Treated in US Pivotal TrialNovember 14th, 2024
Are Athletes Getting More Injuries from TOS?July 22nd, 2019
Blood Clots Have Become an Alarming Trend Among Hockey PlayersJanuary 13th, 2018- Join now to see all
